These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9572411)

  • 41. Models of cost-effectiveness of recombinant FSH versus urinary FSH.
    Al-Inany H; Afnan M
    Hum Reprod; 2002 Jun; 17(6):1671-3; author reply 1673-4. PubMed ID: 12042297
    [No Abstract]   [Full Text] [Related]  

  • 42. Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles.
    Kolibianakis EM; Albano C; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5632-7. PubMed ID: 14671145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful pregnancy after treatment with recombinant human follicle stimulating hormone.
    Chuong CJ; Young RL; Boesch CL; Lewallen NB; Reilly M
    Lancet; 1993 Apr; 341(8852):1101. PubMed ID: 8097004
    [No Abstract]   [Full Text] [Related]  

  • 44. Inadvertent recombinant human follicle stimulating hormone bolus instead of human chorionic gonadotrophin leads to the retrieval of competent oocytes in IVF program.
    Bianchi V; Dal Prato L; Maccolini A; Mazzone S; Borini A
    Fertil Steril; 2009 Nov; 92(5):1747.e1-3. PubMed ID: 19732874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The value of recombinant gonadotropins in treatment of infertility].
    Breckwoldt M; De Geyter C; Schneider HP; Simoni M; Strowitzki T
    Zentralbl Gynakol; 1996; 118(3):176-8. PubMed ID: 8900610
    [No Abstract]   [Full Text] [Related]  

  • 46. Highly purified human-derived follicle-stimulating hormone (Bravelle) has equivalent efficacy to follitropin-beta (Follistim) in infertile women undergoing in vitro fertilization.
    Dickey RP; Nichols JE; Steinkampf MP; Gocial B; Thornton M; Webster BW; Bello SM; Crain J; Marshall DC;
    Reprod Biol Endocrinol; 2003 Oct; 1():63. PubMed ID: 14609434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
    Devroey P; Fauser BC; Platteau P; Beckers NG; Dhont M; Mannaerts BM
    J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome.
    Aboulghar M; Saber W; Amin Y; Aboulghar M; Mansour R; Serour G
    Fertil Steril; 2010 Nov; 94(6):2332-4. PubMed ID: 20188364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of recombinant follicle-stimulating hormone on bone turnover markers in infertile women undergoing in vitro fertilization procedure.
    Omodei U; Mazziotti G; Donarini G; Gola M; Guella V; Pagani F; Bugari G; Porcelli T; Giustina A
    J Clin Endocrinol Metab; 2013 Jan; 98(1):330-6. PubMed ID: 23093489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands.
    Fragoulakis V; Pescott CP; Smeenk JM; van Santbrink EJ; Oosterhuis GJ; Broekmans FJ; Maniadakis N
    Appl Health Econ Health Policy; 2016 Dec; 14(6):719-727. PubMed ID: 27581117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness.
    Gerli S; Casini ML; Unfer V; Costabile L; Bini V; Di Renzo GC
    Fertil Steril; 2004 Sep; 82(3):573-8. PubMed ID: 15374698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pregnancy results in in vitro fertilization in one case of luteinized-unruptured-follicle syndrome].
    Letouzey V; Reyftmann L; Hamamah S; Hédon B
    Gynecol Obstet Fertil; 2008 Jan; 36(1):60-2. PubMed ID: 18248842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.
    Bergh C; Howles CM; Borg K; Hamberger L; Josefsson B; Nilsson L; Wikland M
    Hum Reprod; 1997 Oct; 12(10):2133-9. PubMed ID: 9402268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New approaches to achieving human fertilization: a résumé.
    Edwards RG
    Hum Reprod; 1998 Jun; 13 Suppl 3():127-36; discussion 145-7. PubMed ID: 9755419
    [No Abstract]   [Full Text] [Related]  

  • 55. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF.
    Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Fauser BC; Broekmans FJ
    Hum Reprod; 2007 Jul; 22(7):1919-24. PubMed ID: 17485438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ovarian stimulation in women undergoing in-vitro fertilization and embryo transfer using recombinant human follicle stimulating hormone (Gonal-F) in non-down-regulated cycles.
    Strowitzki T; Kentenich H; Kiesel L; Neulen J; Bilger W
    Hum Reprod; 1995 Dec; 10(12):3097-101. PubMed ID: 8822421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients.
    Escudero E; Bosch E; Crespo J; Simón C; Remohí J; Pellicer A
    Fertil Steril; 2004 Mar; 81(3):562-6. PubMed ID: 15037403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Local reaction to s.c. injections of a recombinant gonadotrophin preparation possibly related to the osmolality of the reconstituted solution.
    Sohan K; Cahill D; Stegmann M
    Hum Reprod; 1999 Jul; 14(7):1921. PubMed ID: 10402420
    [No Abstract]   [Full Text] [Related]  

  • 59. What are the clinical benefits of recombinant gonadotrophins? Recombinant follicle stimulating hormone.
    Bergh C
    Hum Reprod; 1999 Jun; 14(6):1418-20. PubMed ID: 10357950
    [No Abstract]   [Full Text] [Related]  

  • 60. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group.
    Hum Reprod; 1998 Nov; 13(11):3023-31. PubMed ID: 9853849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.